HOME >> MEDICINE >> NEWS
Study shows patch therapy may be as effective as oral medications

Altoona, Pa., March 31, 2005 Researchers from the Altoona Arthritis and Osteoporosis Center announced today that data presented at the 24th Annual Scientific Meeting of the American Pain Society suggest that patch therapy provides similar pain relief as oral medications for patients with osteoarthritis (OA) knee pain. The exploratory study involved a head to head comparison of applying the lidocaine patch 5% (Lidoderm) or taking celecoxib (Celebrex) 200 mg per day.

In this study, results showed that at six weeks 54 % of patients treated in the lidocaine patch 5% (Lidoderm) group (N=56) and 62 % of patients in the celecoxib (Celebrex) group (N=63) experienced a 30 % or greater improvement in pain intensity. A 30 % or greater reduction in pain intensity is considered clinically meaningful to pain patients.

"These findings are encouraging for OA knee pain patients wanting alternatives to current oral medications," said Dr. Alan J. Kivitz, founder and lead physician, Altoona Arthritis and Osteoporosis Center, and study author. "With medication safety being on the minds of many people, it's promising for patients and their physicians that there are non-systemic therapies being studied for OA pain which may provide future options."

OA affects more than 20 million Americans annually and generates more than seven million physician visits per year. If left untreated, chronic pain conditions such as OA can have significant physical, psychological and financial consequences by impacting daily functioning and quality of life.

Analyzing results from 143 patients experiencing OA pain of either one or both knees, the randomized, open-label, active-control, parallel-group study found that clinically meaningful reductions in pain were noted in the lidocaine patch 5% and the celecoxib groups at week 12. In this study, 71 percent of patients in the lidocaine patch 5% group (N=24) and 72 percent of patients in the celecoxib group (N=39) experi
'"/>

Contact: Darren Roberts
darren_roberts@nyc.cohnwolfe.com
212-798-9778
Cohn & Wolfe
31-Mar-2005


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows soy is well accepted in school lunches
4. Study finds that coordinating care of chronically ill patients does not increase liability
5. Study provides new estimates of the causes of child mortality worldwide
6. Study finds factors linked to substance use disorder relapse among health care professionals
7. Study finds majority of women willing to accept cervical cancer vaccine for self and children
8. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
9. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
10. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
11. Study of obese diabetics explains why low-carb diets produce fast results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/15/2019)... ... March 15, 2019 , ... The National Association of Chain ... controlled substance prescriptions for Schedule II through Schedule VI, which will help prevent opioid ... will become effective January 1, 2021. , NACDS recognizes the leadership of ...
(Date:3/15/2019)... ... March 15, 2019 , ... The National Association of ... to a seven-day supply the initial prescriptions of opioids for acute pain – ... (CDC) guidelines for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The ... Friday, March 15th at the Bellevue Club in Bellevue, Washington. GBM is short for ... EBCI and its sponsors and partners invite current and past brain cancer patients, survivors, ...
(Date:3/14/2019)... ... 14, 2019 , ... The National University System ... Sanford Harmony —today announced a new partnership with the Alliance for a ... lifelong healthy habits. The partnership will focus on building awareness of the integral ...
(Date:3/14/2019)... Va. (PRWEB) , ... March 14, 2019 , ... Cell ... FDA Approval, **An FDAnews Webinar**, Thursday, March 28, 2019, 1:30 p.m. - 3:00 p.m. ... approving 10 to 20 cell and gene therapy products a year. , That ...
Breaking Medicine News(10 mins):
(Date:3/12/2019)... ... March 13, 2019 , ... The nation's top provider of ... its upcoming workshops. The code to use for obtaining the discount is R3SCT500. , ... therapies having been performed to date. Last year, R3 began its first stem cell ...
(Date:3/12/2019)... ... March 12, 2019 , ... Global Lyme Alliance (GLA), ... research, education and awareness, today announced it has partnered with the state of ... course for physicians and other healthcare professionals. , This Continuing Medical Education ...
(Date:3/12/2019)... ... March 12, 2019 , ... Ventura County Board ... Health Champion at Work award. , Health Champion award recipients are recognized for ... making Ventura County the healthiest county in California. , Guided by a ...
Breaking Medicine Technology:
Cached News: